Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone.

Pesavento R, Filippi L, Pagnan A, Visonà A, Pauletto P, Vescovo G, Cuppini S, Beltramello G, Villalta S, De Conti G, Vedovetto V, Frigo AC, Prandoni P; PROVE Investigators Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1277-9. doi: 10.1164/rccm.201312-2251LE. No abstract available.

PMID:
24832746
2.

Interface design and contemporary: human creating new guidelines for high-tech products.

Pagnan AS, Ribeiro GF, Gonçalves MG, Câmara JJ, Baptista SM.

Work. 2012;41 Suppl 1:1524-30. doi: 10.3233/WOR-2012-0347-1524.

PMID:
22316931
3.

Ergonomics analysis of the productive environment of fashion clothing firm in Belo Horizonte-MG.

Pagnan AS, Câmara JJ.

Work. 2012;41 Suppl 1:1261-7. doi: 10.3233/WOR-2012-0311-1261.

PMID:
22316892
4.

von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.

Casonato A, Sponga S, Pontara E, Cattini MG, Basso C, Thiene G, Cella G, Daidone V, Gerosa G, Pagnan A.

Thromb Haemost. 2011 Jul;106(1):58-66. doi: 10.1160/TH10-10-0634. Epub 2011 May 5.

PMID:
21544311
5.

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Daidone V, Gallinaro L, Grazia Cattini M, Pontara E, Bertomoro A, Pagnan A, Casonato A.

Haematologica. 2011 Jun;96(6):881-7. doi: 10.3324/haematol.2010.036848. Epub 2011 Mar 10.

6.

The value of 64-detector row computed tomography for the exclusion of pulmonary embolism.

Pesavento R, de Conti G, Minotto I, Filippi L, Mongiat M, de Faveri D, Maurizi F, Dalla Valle F, Piovella C, Pagnan A, Prandoni P; TACEP study.

Thromb Haemost. 2011 May;105(5):901-7. doi: 10.1160/TH10-10-0638. Epub 2011 Feb 8.

PMID:
21301781
7.

A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P.

J Thromb Haemost. 2010 Nov;8(11):2450-7. doi: 10.1111/j.1538-7836.2010.04044.x.

8.

Comparison of methods for determination of glomerular filtration rate in hypertensive subjects with normal serum creatinine.

Mazza A, Montemurro D, Piccoli A, Pagnan A, Pessina AC, Rampin L, Schiavon L, Zuin M, Rubello D, Zamboni S.

Blood Press. 2010 Oct;19(5):278-86. doi: 10.3109/08037051003718473.

PMID:
20334577
9.

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.

Casonato A, Gallinaro L, Cattini MG, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.

Haematologica. 2010 Aug;95(8):1366-72. doi: 10.3324/haematol.2009.019927. Epub 2010 Mar 19.

10.

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

Casonato A, Gallinaro L, Cattini MG, Sartorello F, Pontara E, Padrini R, Bertomoro A, Daidone V, Pagnan A.

Transl Res. 2010 Apr;155(4):200-8. doi: 10.1016/j.trsl.2009.12.003. Epub 2009 Dec 30.

PMID:
20303469
11.

Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome.

Daidone V, Pontara E, Romualdi C, Cattini MG, Scaroni C, Albiger N, Pagnan A, Casonato A.

Thromb Res. 2010 Jun;125(6):e275-80. doi: 10.1016/j.thromres.2010.01.031. Epub 2010 Feb 13.

PMID:
20156642
12.

Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey.

Prandoni P, Pesavento R, Sørensen HT, Gennaro N, Dalla Valle F, Minotto I, Perina F, Pengo V, Pagnan A.

Eur J Intern Med. 2009 Sep;20(5):470-3. doi: 10.1016/j.ejim.2009.06.001. Epub 2009 Jul 4.

PMID:
19712846
13.

Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center.

Sartori MT, Imbergamo S, Zanon E, Bonaccorso G, Pittoni G, Feltracco P, Ori C, Pagnan A, Cella G.

Clin Appl Thromb Hemost. 2009 Dec;15(6):628-35. doi: 10.1177/1076029609335909. Epub 2009 Jul 14.

PMID:
19605376
14.

Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions.

Daidone V, Cattini MG, Pontara E, Sartorello F, Gallinaro L, Marotti A, Scaroni C, Pagnan A, Casonato A.

Thromb Haemost. 2009 Feb;101(2):298-304.

PMID:
19190813
15.

Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients.

Spiezia L, Radu C, Marchioro P, Bertini D, Rossetto V, Castelli M, Pagnan A, Sørensen B, Simioni P.

Thromb Haemost. 2008 Dec;100(6):1106-10.

PMID:
19132237
16.

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.

Sztukowska M, Gallinaro L, Cattini MG, Pontara E, Sartorello F, Daidone V, Padrini R, Pagnan A, Casonato A.

Br J Haematol. 2008 Oct;143(1):107-14. doi: 10.1111/j.1365-2141.2008.07311.x. Epub 2008 Aug 7.

PMID:
18691167
17.

Endothelial dysfunction in haemophilia patients.

Sartori MT, Bilora F, Zanon E, Varvarikis C, Saggiorato G, Campagnolo E, Pagnan A, Cella G.

Haemophilia. 2008 Sep;14(5):1055-62. doi: 10.1111/j.1365-2516.2008.01808.x. Epub 2008 Jul 8.

PMID:
18624700
18.

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A.

Blood. 2008 Apr 1;111(7):3540-5. doi: 10.1182/blood-2007-11-122945. Epub 2008 Feb 1.

19.

Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.

Casonato A, Daidone V, Sartorello F, Albiger N, Romualdi C, Mantero F, Pagnan A, Scaroni C.

Br J Haematol. 2008 Jan;140(2):230-5. doi: 10.1111/j.1365-2141.2007.06907.x.

PMID:
18173757
20.

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.

Casonato A, Sartorello F, Pontara E, Gallinaro L, Bertomoro A, Grazia Cattini M, Daidone V, Szukowska M, Pagnan A.

Thromb Haemost. 2007 Dec;98(6):1182-7.

PMID:
18064311
21.

Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.

Sartori MT, Serena A, Saggiorato G, Campei S, Faggian D, Pagnan A, Paternoster DM.

J Thromb Haemost. 2008 Feb;6(2):352-8. Epub 2007 Nov 15.

22.

Porphyrin-photosensitized processes: their applications in the prevention of arterial restenosis.

Magaraggia M, Marigo L, Pagnan A, Jori G, Visonà A.

Cardiovasc Hematol Agents Med Chem. 2007 Oct;5(4):278-88. Review.

PMID:
17979690
23.

Acute oppressive chest pain in a 66-year-old woman with a recent Amplatzer device closure of patent foramen ovale.

Spiezia L, Rossetto V, Zuin A, Pagnan A, Simioni P.

Intern Emerg Med. 2007 Oct;2(3):229-30. Epub 2007 Oct 1. No abstract available.

PMID:
17912492
24.

Identifying carriers of type 2N von Willebrand disease: procedures and significance.

Casonato A, Pontara E, Sartorello F, Cattini MG, Perutelli P, Bertomoro A, Gallinaro L, Pagnan A.

Clin Appl Thromb Hemost. 2007 Apr;13(2):194-200.

PMID:
17456630
25.

Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.

Casonato A, De Marco L, Gallinaro L, Sztukowska M, Mazzuccato M, Battiston M, Pagnan A, Ruggeri ZM.

Thromb Haemost. 2007 Apr;97(4):527-33.

PMID:
17393013
26.

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.

27.

Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Sartorato P, Zulian E, Benedini S, Mariniello B, Schiavi F, Bilora F, Pozzan G, Greggio N, Pagnan A, Mantero F, Scaroni C.

J Clin Endocrinol Metab. 2007 Mar;92(3):1015-8. Epub 2007 Jan 2.

PMID:
17200174
28.

The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism.

Vigo M, Pesavento R, Bova C, Porro F, Ghirarduzzi A, Bazzan M, Polverosi R, Frulla M, Noto A, Castelli R, Giovanardi F, Angelini F, Pagnan A, Prandoni P; SCENIC Investigators Group.

Semin Thromb Hemost. 2006 Nov;32(8):831-7.

PMID:
17171597
29.

Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease.

Casonato A, Gallinaro L, Pontara E, Bernardo L, Sartorello F, Daidone V, Pagnan A.

Thromb Res. 2007;120(3):451-3. Epub 2006 Dec 15. No abstract available.

PMID:
17157361
30.

Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.

Gallinaro L, Sartorello F, Pontara E, Cattini MG, Bertomoro A, Bartoloni L, Pagnan A, Casonato A.

Thromb Haemost. 2006 Dec;96(6):711-6.

PMID:
17139363
31.

Postthrombotic syndrome.

Pesavento R, Bernardi E, Concolato A, Dalla Valle F, Pagnan A, Prandoni P.

Semin Thromb Hemost. 2006 Oct;32(7):744-51. Review.

PMID:
17024603
32.

Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis.

Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sørensen H, Pesavento R, Iotti M, Casiglia E, Iliceto S, Pagnan A, Lensing AW.

J Thromb Haemost. 2006 Sep;4(9):1891-6.

33.

Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.

Casonato A, Fabris F, Pontara E, Cattini MG, Zocca N, Gallinaro L, Girolami A, Pagnan A.

Clin Appl Thromb Hemost. 2006 Jul;12(3):296-304.

PMID:
16959682
34.

Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors.

Albiger N, Testa RM, Almoto B, Ferrari M, Bilora F, Petrobelli F, Pagnan A, Mantero F, Scaroni C.

Horm Metab Res. 2006 Jun;38(6):405-10.

PMID:
16823723
35.

Cerebral venous thrombosis as a rare onset of Churg-Strauss syndrome.

Teresa Sartori M, Briani C, Munari M, Amistà P, Pagnan A, Zampieri P.

Thromb Haemost. 2006 Jul;96(1):90-2. No abstract available.

PMID:
16807658
36.

Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.

Cella G, Marchetti M, Vignoli A, Randi ML, Saggiorato G, Pasetto L, Pagnan A, Barbui T, Falanga A.

Leukemia. 2006 Aug;20(8):1430-4. Epub 2006 Jun 15.

PMID:
16775616
37.

Does hemophilia protect against atherosclerosis? A case-control study.

Bilora F, Zanon E, Petrobelli F, Cavraro M, Prandoni P, Pagnan A, Girolami A.

Clin Appl Thromb Hemost. 2006 Apr;12(2):193-8.

PMID:
16708121
38.

The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.

De Stefano V, Simioni P, Rossi E, Tormene D, Za T, Pagnan A, Leone G.

Haematologica. 2006 May;91(5):695-8.

39.

Identifying type Vicenza von Willebrand disease.

Casonato A, Pontara E, Sartorello F, Cattini MG, Gallinaro L, Bertomoro A, Rosato A, Padrini R, Pagnan A.

J Lab Clin Med. 2006 Feb;147(2):96-102.

PMID:
16459168
40.

Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.

Brugge JM, Simioni P, Bernardi F, Tormene D, Lunghi B, Tans G, Pagnan A, Rosing J, Castoldi E.

J Thromb Haemost. 2005 Dec;3(12):2695-702.

41.

Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts.

Cozzi E, Simioni P, Boldrin M, Seveso M, Calabrese F, Baldan N, Busetto R, Tormene D, Gavasso S, Castagnaro M, Echelard Y, Rice T, Plebani M, Carraro P, Bosio E, Valente M, Pagnan A, Thiene G, Ancona E.

Transplantation. 2005 Nov 27;80(10):1501-10.

PMID:
16340797
42.

Inactivation of vascular smooth muscle cells photosensitised by liposome-delivered Zn(II)-phthalocyanine.

Magaraggia M, Visonà A, Furlan A, Pagnan A, Miotto G, Tognon G, Jori G.

J Photochem Photobiol B. 2006 Jan 2;82(1):53-8. Epub 2005 Oct 21.

PMID:
16243532
43.
44.

Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.

Simioni P, Morboeuf O, Tognin G, Gavasso S, Tormene D, Woodhams B, Pagnan A.

Thromb Res. 2006;117(5):523-8.

PMID:
15921724
45.

Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population.

Sartori MT, Spiezia L, Cesaro S, Messina C, Paris M, Pillon M, Saggiorato G, Pagnan A, Girolami A, Zanesco L, Cella G.

Thromb Haemost. 2005 Apr;93(4):682-9.

PMID:
15841312
46.

The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns.

Zanardo V, Savio V, Sabrina G, Franzoi M, Zerbinati P, Fadin M, Tognin G, Tormene D, Pagnan A, Simioni P.

Blood Coagul Fibrinolysis. 2005 Apr;16(3):177-81.

PMID:
15795535
47.

A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function.

Casonato A, Cattini MG, Soldera C, Marcato S, Sartorello F, Pontara E, Pagnan A.

J Lab Clin Med. 2004 Nov;144(5):254-9.

PMID:
15570243
48.

Whipple's disease.

D'Incà R, Pagnan A, Vettorato MG, Ingravallo G, Rugge M, Sturniolo GC.

Gastrointest Endosc. 2004 Nov;60(5):800-1. No abstract available.

PMID:
15557962
49.

Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial.

Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A.

Ann Intern Med. 2004 Aug 17;141(4):249-56.

PMID:
15313740
50.

The G20210A prothrombin gene mutation: is there room for screening families?

Tormene D, Simioni P, Pagnan A, Prandoni P.

J Thromb Haemost. 2004 Aug;2(8):1487-8. No abstract available.

Supplemental Content

Loading ...
Support Center